|
MBD2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
3.1696000268866E-09 |
| Normal-vs-Stage3 |
9.99200722162641E-16 |
| Normal-vs-Stage4 |
4.99611463311567E-12 |
| Stage1-vs-Stage2 |
8.605800E-01 |
| Stage1-vs-Stage3 |
7.624000E-01 |
| Stage1-vs-Stage4 |
4.452600E-01 |
| Stage2-vs-Stage3 |
9.958000E-01 |
| Stage2-vs-Stage4 |
7.416400E-01 |
| Stage3-vs-Stage4 |
6.414600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
2.47929999996899E-06 |
| Normal-vs-Asian |
1.65012448150037E-12 |
| Caucasian-vs-AfricanAmerican |
4.092400E-01 |
| Caucasian-vs-Asian |
2.908400E-01 |
| AfricanAmerican-vs-Asian |
2.592400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.99076344087734E-13 |
| Normal-vs-Female |
1.65156777143238E-12 |
| Male-vs-Female |
3.186800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.23154827949656E-14 |
| Normal-vs-Age(41-60Yrs) |
1.66533453693773E-15 |
| Normal-vs-Age(61-80Yrs) |
1.62680979798324E-12 |
| Normal-vs-Age(81-100Yrs) |
5.51409999999253E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.006800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.921000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.555400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.685180E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.479400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.074000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.063600E-01 |
| Classical-VS-Follicular |
8.535200E-01 |
| Classical-VS-Other |
5.647400E-01 |
| Classical-VS-Normal |
7.38076266770804E-13 |
| Tall-VS-Follicular |
8.094200E-01 |
| Tall-VS-Other |
5.940800E-01 |
| Tall-VS-Normal |
2.6534996422356E-10 |
| Follicular-VS-Other |
6.209200E-01 |
| Follicular-VS-Normal |
5.65669733276764E-11 |
| Other-VS-Normal |
3.042600E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
3.13019610231891E-11 |
| N0-vs-N1 |
9.124400E-01 |
|
|
